8 years ago

Congenica Secures Series B Funding Led by BGI Genomics and Healthlink Capital

  • Congenica, a Cambridge, England-based provider of clinical genomics software for inherited diseases, has completed its Series B funding round of undisclosed amount

  • The round was participated by BGI Genomics, Healthlink Capital, an unnamed China-based life-science investor, and Future Planet Capital

  • BGI Genomics and UniteGen, Healthlink's associated clinical diagnostic lab, have signed commercial contracts to use Congenica's Sapientia software in China

  • Congenica's Sapientia platform analyzes genome-scale DNA data to produce comprehensive diagnostic reports for rare genetic diseases.

      • ProblemHealthcare

      "Diagnosing inherited diseases is difficult, often requiring multiple tests and specialist consultations, leading to long wait times and delayed treatment."

      Solution

      "Congenica's Sapientia software platform analyzes genome-scale DNA data, producing a comprehensive diagnostic report linked to patient symptoms, aiding clinicians in diagnosing rare genetic diseases and making faster, more informed decisions."

      Covered on